MA45272A - Produits issus de liquide amniotique et procédés d'utilisation - Google Patents
Produits issus de liquide amniotique et procédés d'utilisationInfo
- Publication number
- MA45272A MA45272A MA045272A MA45272A MA45272A MA 45272 A MA45272 A MA 45272A MA 045272 A MA045272 A MA 045272A MA 45272 A MA45272 A MA 45272A MA 45272 A MA45272 A MA 45272A
- Authority
- MA
- Morocco
- Prior art keywords
- methods
- amniotic fluid
- fluid products
- products
- amniotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Microbiology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562185605P | 2015-06-27 | 2015-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45272A true MA45272A (fr) | 2018-05-02 |
Family
ID=56404318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA045272A MA45272A (fr) | 2015-06-27 | Produits issus de liquide amniotique et procédés d'utilisation |
Country Status (4)
Country | Link |
---|---|
US (2) | US11559553B2 (fr) |
EP (1) | EP3313986A1 (fr) |
MA (1) | MA45272A (fr) |
WO (1) | WO2017003954A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA45272A (fr) | 2015-06-27 | 2018-05-02 | Stimlabs Llc | Produits issus de liquide amniotique et procédés d'utilisation |
US10960027B2 (en) | 2016-03-23 | 2021-03-30 | Mimedx Group, Inc. | Compositions and methods of treatment with amniotic fluid |
JP6373444B1 (ja) * | 2017-05-10 | 2018-08-15 | 株式会社ホルス | 羊膜由来原料の製造方法、化粧品の製造方法及び健康食品の製造方法 |
US11590175B2 (en) | 2017-08-23 | 2023-02-28 | Merakris Therapeutics Llc | Compositions containing amniotic components and methods for preparation and use thereof |
CN108379094B (zh) * | 2018-04-24 | 2021-09-14 | 广州暨南大学医药生物技术研究开发中心有限公司 | 包含生物活性美容多肽脂质立方晶的组合物及其在化妆品中的应用 |
CN110223246B (zh) * | 2019-05-17 | 2021-05-18 | 杭州趣维科技有限公司 | 一种多风格人像美颜磨皮方法及装置 |
TR201917367A2 (tr) * | 2019-11-08 | 2021-05-21 | Ercuement Ovali | Saç dökülmesi̇ ve skar tedavi̇si̇nde kullanima uygun bi̇r ürünün üreti̇mi̇ i̇çi̇n bi̇r yöntem |
US20210315939A1 (en) * | 2020-04-10 | 2021-10-14 | Organicell Regenerative Medicine, Inc. | Compositions comprising nanoparticles, method of making and uses thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001944A (en) | 1975-08-25 | 1977-01-11 | Parke, Davis & Company | Freeze-drying process |
DE60233248D1 (de) * | 2001-11-15 | 2009-09-17 | Childrens Medical Center | Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon |
EP1549328A4 (fr) | 2002-09-18 | 2009-07-08 | Emiliano Ghinelli | Utilisation d'une composition a base de membrane amniotique humaine dans la prophylaxie et le traitement de maladies et d'etats pathologiques de l'oeil et de la peau |
US7191068B2 (en) | 2003-03-25 | 2007-03-13 | Proteogenix, Inc. | Proteomic analysis of biological fluids |
WO2005017117A2 (fr) | 2003-08-14 | 2005-02-24 | Martin Haas | Cellules souches foetales amniotiques pluripotentes (mafsc) et constitution de banques de celles-ci |
WO2006091546A2 (fr) | 2005-02-22 | 2006-08-31 | The Johns Hopkins School Of Medicine | Utilisation du fluide amniotique en traitement d'affections et de lesions oculaires |
US8376984B2 (en) | 2005-07-14 | 2013-02-19 | Terry L. James | Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin |
WO2007046501A1 (fr) | 2005-10-21 | 2007-04-26 | Kaneka Corporation | Matériel de séparation de cellules souches et méthode de séparation |
US20080227208A1 (en) * | 2007-03-16 | 2008-09-18 | Hsiao-Ching Yee | Devices and Methods for Detection of Occult Blood |
KR101078419B1 (ko) | 2009-03-20 | 2011-10-31 | 주식회사 스템메디언스 | 양수 내 태아 유래 중간엽줄기세포를 이용한 피부 상태개선용 조성물 |
US20140050705A1 (en) * | 2011-02-25 | 2014-02-20 | Kyungpook National University Hospital | Agent for treating urinary incontinence including stem cells derived from amniotic fluid |
US20120276215A1 (en) * | 2011-04-26 | 2012-11-01 | Riordan Neil H | Therapeutic Conditioned Media |
EP2717888B1 (fr) * | 2011-06-10 | 2020-09-09 | Tissuetech, Inc. | Procédés de traitement de tissus foetaux de support |
US20130218274A1 (en) | 2011-12-02 | 2013-08-22 | Mimedx Group, Inc. | Shredded tissue grafts and methods for making and using the same |
US8940294B2 (en) | 2012-03-02 | 2015-01-27 | Tissuetech, Inc. | Methods of isolating and culturing stem cells |
ES2756332T3 (es) | 2012-09-10 | 2020-04-27 | Univ Wake Forest Health Sciences | Membrana amniótica y su uso en cicatrización de heridas y construcciones de ingeniería tisular |
US10485521B2 (en) | 2013-05-10 | 2019-11-26 | MAM Holdings of West Florida, L.L.C. | Method for obtaining sterile human amniotic fluid and uses thereof |
US20140336600A1 (en) | 2013-05-10 | 2014-11-13 | Carl Randall Harrell | Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof |
WO2014185945A1 (fr) | 2013-05-13 | 2014-11-20 | Cormatrix Cardiovascular, Inc. | Compositions, méthodes et systèmes associés à des substances cosmétiques régénératives |
EP3038630B1 (fr) * | 2013-08-30 | 2020-03-18 | MIMEDX Group Inc. | Compositions placentaires micronisées comprenant un chélateur |
US20150140114A1 (en) | 2013-11-19 | 2015-05-21 | John R. SASKO | Skin treatment protocol utilizing amniotic solution |
TW201603818A (zh) * | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
MA45272A (fr) | 2015-06-27 | 2018-05-02 | Stimlabs Llc | Produits issus de liquide amniotique et procédés d'utilisation |
-
0
- MA MA045272A patent/MA45272A/fr unknown
-
2016
- 2016-06-27 EP EP16736979.2A patent/EP3313986A1/fr active Pending
- 2016-06-27 WO PCT/US2016/039668 patent/WO2017003954A1/fr active Application Filing
- 2016-06-27 US US15/739,567 patent/US11559553B2/en active Active
-
2022
- 2022-12-14 US US18/081,136 patent/US20230126319A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11559553B2 (en) | 2023-01-24 |
US20230126319A1 (en) | 2023-04-27 |
US20180311283A1 (en) | 2018-11-01 |
EP3313986A1 (fr) | 2018-05-02 |
WO2017003954A1 (fr) | 2017-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264439A (en) | Nucleic acid products and methods of administering them | |
MA46427A (fr) | Compositions d'oligonucléotides et procédés associés | |
DK3265448T3 (da) | Riluzol-prodrugs og anvendelse deraf | |
DK3502253T3 (da) | Hidtil ukendte crispr-enzymer og -systemer | |
MA40876A (fr) | Procédés d'obtention de plants greffés à hauteur améliorée et produits associés | |
EP3200804A4 (fr) | Formulations de polysaccharides et d'acides nucléiques contenant des agents réducteurs de viscosité | |
HK1252917A1 (zh) | 能夠在多個平台上區分胎兒性別和胎兒性染色體異常的新方法 | |
ITUB20160730A1 (it) | Dispositivo per la movimentazione di manufatti | |
MA40921A (fr) | Récepteurs antigéniques chimériques anti-cldn et procédés d'utilisation | |
FI20155058A (fi) | Partikkelimuotoinen polymeerituote ja sen käyttö | |
ZA201707822B (en) | Process for the biological production of methacrylic acid and derivatives thereof | |
PL3170912T3 (pl) | Produkt stalowy oraz sposób jego wytwarzania | |
DK3679010T3 (da) | Kulsyre-additionsprodukter | |
FI20155621A (fi) | Menetelmä ja tuote | |
HK1243421A1 (zh) | 檢測核酸的組合物和方法 | |
GB2563504B (en) | Fluid container diffuser system and related method of use | |
IL252992B (en) | Grape products for non-alcoholic fatty liver disease and other uses | |
MA40512A (fr) | Anticorps de l'angiopoïétine-like 4 et procédés d'utilisation correspondants | |
FI20165406A (fi) | Lannoite ja menetelmä sen valmistamiseksi ja lannoitetuotteen käyttö | |
PL3186290T3 (pl) | Stały katalizator dla (ko)polimeryzacji alfa-olefin i sposób jego wytwarzania | |
ITUB20169910A1 (it) | Macchinario per la movimentazione di oggetti | |
MA45272A (fr) | Produits issus de liquide amniotique et procédés d'utilisation | |
FI20155429A (fi) | Hiova tuote ja menetelmä sen valmistamiseksi | |
ZA201903845B (en) | Fgfr4 inhibitor and preparation method and use thereof | |
MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine |